— Know what they know.
Not Investment Advice
Also trades as: CAMX.ST (STO) · $vol 7M · 0RD1.L (LSE) · $vol 2M

CAMRF OTC

Camurus AB
1W: +0.0% 1M: -3.5% 3M: +14.3% YTD: -8.0% 1Y: -10.3% 3Y: +183.1% 5Y: +378.7%
$61.75
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $3.7B mcap · 39M float · 0.0003% daily turnover · Short 80% of daily vol

Income Trends

Revenue
$2.3B +21.3% ▲
5Y CAGR: +46.5%
Gross Profit
$2.1B +21.4% ▲
5Y CAGR: +47.6%
Operating Income
$874M +86.3% ▲
Net Income
$736M +71.7% ▲
EPS (Diluted)
$12.26 +70.3% ▲
EBITDA
$964M +69.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$601M$956M$1.7B$1.9B$2.3B
YoY Growth+78.7%+59.2%+79.5%+8.8%+21.3%
Cost of Revenue$85M$103M$122M$130M$156M
Gross Profit$515M$853M$1.6B$1.7B$2.1B
Gross Margin85.8%89.2%92.9%93.1%93.1%
R&D Expenses$389M$474M$638M$684M$517M
SG&A Expenses$240M$309M$424M$584M$708M
Operating Expenses$628M$782M$1.1B$1.3B$1.2B
Operating Income-$111M$72M$526M$469M$874M
Operating Margin-18.4%7.5%30.6%25.1%38.6%
Interest Expense$1M$2M$1M$1M$6M
Income Before Tax-$112M$73M$549M$553M$933M
Tax Expense-$21M$18M$118M$124M$198M
Net Income-$90M$56M$431M$428M$736M
Net Margin-15.1%5.8%25.1%22.9%32.5%
EPS (Diluted)$-1.66$1.01$7.50$7.20$12.26
EBITDA-$98M$87M$565M$568M$964M
Shares Outstanding54M55M57M59M60M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms